| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.58 | 0.03 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.57 | 0.04 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.49 | 0.1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.31 | 0.1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.26 | 0.4 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.22 | 5e-07 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.19 | 3e-05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-07 |